Nebius (NBIS) stock rated a sell: unprofitability, negative FCF, heavy CapEx and dilution risks despite AI deals.

Mapping Capital Concentration in a $65 Billion Economy BUSINESS ANALYSIS | THE INDEPENDENT | Uganda’s private capital class is expanding faster than its capital markets. In an economy where public ...

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2025 Earnings Call Transcript February 26, 2026 Amphastar Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.73 EPS, ...

Discover the best institutional custody solutions for tokenized assets in 2026. Secure your RWAs with top-tier providers like ...

Explore 5 structured crypto presales with updated pricing, allocation ratios, and funds raised. A data-driven look at ongoing opportunities in 2026.

When commercial property owners need roofing services, selecting the right contractor can mean the difference between a roof ...

Billions spent on AI, but ROI is missing from your bottom line. Learn why the AI monetization crisis is real and three steps to close the AI value gap now.